| Enrolment | Allocation | Primary study period | Follow-up | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Timepoint | −1d | 0 | PRE: 0–30 min | OLV for 30 min | 5 min after the end of OLV | PACU | POD 1 | POD 2 | POD 3–7 | POD 30 | POD 60 |
Enrolments | |||||||||||
 Eligibility screen | × |  |  |  |  |  |  |  |  |  |  |
 Informed consent | × |  |  |  |  |  |  |  |  |  |  |
 Allocation |  | × |  |  |  |  |  |  |  |  |  |
Interventions | |||||||||||
 TPVB |  |  | × |  |  |  |  |  |  |  |  |
Assessments | |||||||||||
 Baseline information |  |  |  |  |  |  |  |  |  |  |  |
 Composite outcome of PPCs |  |  |  |  |  |  | × | × | × | × | × |
 LUS score | × |  |  |  |  |  | × | × |  |  |  |
 Blood gas analysis | × |  |  | × | × | × |  |  |  |  |  |
 NRS score | × |  |  |  |  |  | × | × |  | × | × |
 QoR-15 score | × |  |  |  |  |  | × | × |  | × | × |
 Complications assessment |  |  |  |  |  | × | × | × | × | × | × |
 Mortality rate |  |  |  |  |  |  |  |  |  | × | × |